Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 54: 444-445, 2008; 10.1373/clinchem.2007.099341
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lorenz, R. G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Lorenz, R. G.
Related Collections
Right arrow Clinical Case Studies
(Clinical Chemistry. 2008;54:444-445.)
© 2008 American Association for Clinical Chemistry, Inc.

Commentaries

Commentary

Robin G. Lorenz

University of Alabama at Birmingham, Birmingham, AL.

Address correspondence to the author at: University of Alabama at Birmingham, 1825 University Blvd., SHEL 602, Birmingham, AL 35294-2182. Fax 205-996-9113; e-mail rlorenz@uab.edu.

The first 20% of the full text of this article appears below.

The gold standard for diagnosis of celiac disease (CD) requires both a duodenal biopsy showing villus blunting, crypt hyperplasia, and increased numbers of intraepithelial lymphocytes (IELs) and a subsequent small intestinal biopsy that shows resolution of these histological findings after the patient is put on a gluten-free diet (1). The development of new serological tests, however, . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Association for Clinical Chemistry.